Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies
- PMID: 11017840
- DOI: 10.1086/314023
Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies
Abstract
A total of 21 patients with hematologic malignancies were given thiabendazole for treatment of strongyloidiasis. Fifteen patients were cured. Since there were no relapses, it is unlikely that maintenance therapy has a role in the management of strongyloidiasis in this population of patients.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
